604 filings
Page 2 of 31
8-K
q3w11qn4q
17 Jul 23
Changes in Registrant's Certifying Accountant
4:15pm
8-K
rovx7k6jz43p4e0rj
29 Jun 23
Results of Operations and Financial Condition
5:15pm
8-K
ce6orjy eo
3 May 23
Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officer
4:15pm
8-K
rkm74td 93
20 Apr 23
Regulation FD Disclosure
10:05am
8-K
ilv7gu30wn8844gbdq6
28 Feb 23
Departure of Directors or Certain Officers
4:36pm
8-K
7rt2dd81ik ajgjf2wc
14 Feb 23
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023
5:10pm
8-K
b5lu0ac ffjdvzr
22 Dec 22
Regulation FD Disclosure
4:21pm
8-K
ym2j5rvf77m j2rnj
28 Nov 22
Entry into a Material Definitive Agreement
4:05pm
8-K
0qkmmyjay6t3a3d0fnav
15 Nov 22
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023
12:36pm
8-K
3ay9f9 3zxe3w05dd8
10 Nov 22
Termination of a Material Definitive Agreement
4:15pm
8-K
3om8zm
2 Nov 22
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
4:30pm
8-K
a2hoop6xkznuem bze
7 Sep 22
Entry into a Material Definitive Agreement
4:35pm
8-K
tg9t3e
26 Aug 22
Termination of a Material Definitive Agreement
4:45pm
8-K
9aaakz
15 Aug 22
Results of Operations and Financial Condition
6:14pm